Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FNKTN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,077
Award facts
- Contract value 100% obligated
- $6,077.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,077.05 to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen (2 ml) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen's comprehensive pharmaceutical prime vendor global contract with DLA, which enables the company to supply a broad range of medications and medical supplies to support military healthcare systems worldwide. Dupixent (dupilumab) is a specialty biologic medication used to treat conditions including moderate-to-severe eczema, asthma, and chronic rhinosinusitis, reflecting the company's role in supplying specialized pharmaceutical products to Defense Health Agency and other federal healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements through competitive award processes, positioning it as a critical vendor for military and veteran healthcare supply chains.
Quick answers
Who was awarded contract SPE2DB25FNKTN?
SPE2DB25FNKTN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FNKTN worth?
The government has obligated $6,077 on SPE2DB25FNKTN.
Is contract SPE2DB25FNKTN an order under another contract?
Yes. SPE2DB25FNKTN is a delivery order under SPE2DB20D1004, an indefinite delivery contract.
Was contract SPE2DB25FNKTN competed?
The extent of competition for SPE2DB25FNKTN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award